Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Editorial
. 2025 Jun;70(6):1946-1947.
doi: 10.1007/s10620-025-09047-2. Epub 2025 Apr 16.

Mirikizumab for Ulcerative Colitis: A Game-Changer or Just Another Incremental Advance?

Bisher Sawaf  1 , Shahem Abbarh  2 , Dahham Alsoud  3
Affiliations
Editorial

Mirikizumab for Ulcerative Colitis: A Game-Changer or Just Another Incremental Advance?

Bisher Sawaf et al. Dig Dis Sci. 2025 Jun.
No abstract available

Keywords: Interleukins; Random clinical trials; Therapeutic monoclonal antibodies; Ulcerative colitis.

PubMed Disclaimer

Conflict of interest statement

Declarations. Conflict of interest: The authors declare no competing interests.

Similar articles

See all similar articles

References

    1. Raine T, Danese S. Breaking through the therapeutic ceiling: what will it take? Gastroenterology 2022;162:1507–1511. - DOI - PubMed
    1. Dubinsky MC, Panaccione R, Lewis JD, et al. Impact of bowel urgency on quality of life and clinical outcomes in patients with ulcerative colitis. Crohn's & Colitis 360 2022; 4:otac016.
    1. D’Haens G, Dubinsky M, Kobayashi T et al. Mirikizumab as Induction and maintenance therapy for ulcerative colitis. N Engl J Med 2023;388:2444–2455. - DOI - PubMed
    1. Dubinsky MC, Clemow DB, Hunter Gibble T et al. Clinical effect of mirikizumab treatment on bowel urgency in patients with moderately to severely active ulcerative colitis and the clinical relevance of bowel urgency improvement for disease remission. Crohns Colitis 2023;5:otac44.
    1. St-Pierre J, Choi D, Fear E et al. Mirikizumab in the treatment of ulcerative colitis: initial real-world data in a population from a large tertiary center. Dig Dis Sci 2025. https://doi.org/10.1007/s10620-025-08950-y - DOI - PubMed

Publication types

LinkOut - more resources